Jonathan Spicer MD PhD (@doctorjspicer) 's Twitter Profile
Jonathan Spicer MD PhD

@doctorjspicer

Medical Director of the McGill Thoracic Oncology Program; Chest surgeon; Neutrophil biologist; Cancer immunologist; Aspiring farmer

ID: 295292758

linkhttp://thoracicsurgery.lab.mcgill.ca/jonathan-spicer.html calendar_today08-05-2011 18:49:26

4,4K Tweet

3,3K Followers

1,1K Following

Waël Hanna (@wc_hanna) 's Twitter Profile Photo

Our pre-proof of "Clinical Utility of Artificial Intelligence-Augmented Endobronchial Ultrasound-Elastography in Lymph Node Staging for Lung Cancer" is now available via JTCVS Techniques buff.ly/3ypTKvL

Our pre-proof of "Clinical Utility of Artificial Intelligence-Augmented Endobronchial Ultrasound-Elastography in Lymph Node Staging for Lung Cancer" is now available via JTCVS Techniques 
buff.ly/3ypTKvL
jonathan Cools (@jonathancools) 's Twitter Profile Photo

medrxiv.org/content/10.110… Here’s some work from Our group suggesting immunologic benefits to nutrition, social support and exercise in lung cancer patients. It’s though to get published in amazed at how controversial TLC for patients is …

jonathan Cools (@jonathancools) 's Twitter Profile Photo

I would add, we’re so focused on drugs and surgery sometimes we forget how much of a difference simple things can make in a persons life. Exercise and nutrition are not life style modification they are medicine

Elliot Servais, MD, FACS (@elliotservaismd) 's Twitter Profile Photo

The Lahey Lung Cancer Screening program has surpassed 30,000 scans 10,500 patients scanned 382 lung cancers detected Cancer detection rate of 3.65% 0.0095 rate of any invasive procedure in patients without cancer Lung Cancer Screening is SAFE and EFFECTIVE

The Lahey Lung Cancer Screening program has surpassed 30,000 scans 

10,500 patients scanned
382 lung cancers detected
Cancer detection rate of 3.65%

0.0095 rate of any invasive procedure in patients without cancer

Lung Cancer Screening is SAFE and EFFECTIVE
Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

5-year follow up of neoadjuvant sintilimab (PD-1) for NSCLC Journal for ImmunoTherapy of Cancer. Pts with resectable NSCLC had 2 doses of sintilimab monotherapy then resection. 5y DFS 65.7% and 5y OS 80.4%. If PD-L1 positive, 5y DFS 71.9% and 5y OS 90.9%. jitc.bmj.com/content/12/8/e…

Jeff Yang MD FACS (@chifujeffyang) 's Twitter Profile Photo

Important & impressive study by Dr. Natalie Lui's team at @stanfordctsurg showing greater ipsilateral rectus muscle atrophy after robotic thoracic surgery compared to open & VATS approaches. Research was painstakingly done. sciencedirect.com/science/articl… Natalie Lui Leah Backhus MD MPH FACS

Daniela (@daniela_molena) 's Twitter Profile Photo

1. #ITSOS2024 is coming up soon! We’re gathering in New York Sept 27-28 to discuss the newest innovations in thoracic #oncology with AATS. We can’t wait to see you there: events.aats.org/itsos24/regist…

Elliot Servais, MD, FACS (@elliotservaismd) 's Twitter Profile Photo

Looking forward to this plenary presentation on Surgical Outcomes w/periop Nivolumab in Checkmate 77T by donington and the privilege to be a discussant. Definitely register and join us at #ITSOS2024 AATS

Looking forward to this plenary presentation on Surgical Outcomes w/periop Nivolumab in Checkmate 77T by <a href="/jdoningtonmd/">donington</a> and the privilege to be a discussant.
Definitely register and join us at #ITSOS2024
<a href="/AATSHQ/">AATS</a>
Hidehito HORINOUCHI (@hhorinouchi) 's Twitter Profile Photo

🔥#WCLC24 abstracts ☢️Advancing Multimodal Therapies in Stage III NSCLC ☑️Chairs: Dr. Feng-Ming Spring Kong Erin A Gillaspie, MD, MPH, FACS 🎙️M.Provencio 🎯APOLO: Phase II Induction Chemo-IO + CRT and Maintenance IO in Stage III NSCLC #LCSM IASLC OncoAlert cattendee.abstractsonline.com/meeting/20598

🔥#WCLC24 abstracts
☢️Advancing Multimodal Therapies in Stage III NSCLC
☑️Chairs: Dr. Feng-Ming Spring Kong <a href="/ErinGillaspie/">Erin A Gillaspie, MD, MPH, FACS</a>
🎙️<a href="/MARIANOPROVENCI/">M.Provencio</a>
🎯APOLO: Phase II Induction Chemo-IO + CRT and Maintenance IO in Stage III NSCLC
#LCSM <a href="/IASLC/">IASLC</a> <a href="/OncoAlert/">OncoAlert</a>
cattendee.abstractsonline.com/meeting/20598
Brendon Stiles (@brendonstilesmd) 's Twitter Profile Photo

Thrilled to participate on this all-star panel of amazing friends and leaders! I'll be joined by Rajika Jindani, MD, MPH, MS, a surgical resident at Montefiore Health System Albert Einstein College of Medicine - Official who I am grateful to sponsor & mentor, as we focus on supporting the Next Generation and the call to "Sponsor Her".

Thrilled to participate on this all-star panel of amazing friends and leaders!  I'll be joined by <a href="/RajikaJindani/">Rajika Jindani, MD, MPH, MS</a>, a surgical resident at <a href="/MontefioreNYC/">Montefiore Health System</a> <a href="/EinsteinMed/">Albert Einstein College of Medicine - Official</a> who I am grateful to sponsor &amp; mentor, as we focus on supporting the Next Generation and the call to "Sponsor Her".
Lorenzo Ferri MD PhD (@lferri123) 's Twitter Profile Photo

Honoured to serve as president of the International Society for Digestive Surgery for 2024-2026. ISDS International Society of Surgery (ISS/SIC) #ISW2024KualaLumpur. Join us at the next International Surgical Week in Mexico City - April 18-23 2026!

Honoured to serve as president of the International Society for Digestive Surgery for 2024-2026. <a href="/IntSocDigSurg/">ISDS</a> <a href="/iss_sic/">International Society of Surgery (ISS/SIC)</a> #ISW2024KualaLumpur.  Join us at the next International Surgical Week in Mexico City - April 18-23 2026!
Patrick Forde (@fordepatrick) 's Twitter Profile Photo

Surprising results, stereotactic radiation plus anti-PD1 for stage 1-2 NSCLC, addition of immunotherapy does not confer benefit #lcsm merck.com/news/merck-pro…

Cecilia Pompili MD PhD FACS (@pompili_cecilia) 's Twitter Profile Photo

This is an extremely important work from Biniam Kidane and team confirming in another setting that #PROs are predicting complications better than traditional objective preop parameters. Same results in our UK population here ⬇️ doi.org/10.1093/ejcts/… #LCSM ESTS IASLC

Isabelle Opitz (@isaopitz) 's Twitter Profile Photo

Don't miss out on our thoracic oncology workshop WS07 #WCLC24 on Sept 7! I’ll share surgical considerations and join the Tumor Board discussion. 2024 World Conference on Lung Cancer in San Diego, USA, Sept 7, 2024 | 10:30 AM UTC-7 Brendon Stiles cattendee.abstractsonline.com/meeting/20598/…